Trial intelligence / Profile preview

Workflow Optimization During Pulse Field Ablation for Atrial Fibrillation

NCT07354217Phase 4Not yet recruiting

Sponsor
National Taiwan University Hospital
Start
Jun 2026
Primary completion
Dec 2030
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of lidocaine in Atrial fibrillation (AFib), sponsored by National Taiwan University Hospital. Planned start Jun 2026; status: not yet recruiting.

02

Drugs

lidocaine
03

Conditions

Atrial fibrillation (AFib)

Beyond the preview

Go deeper on NCT07354217.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07354217.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call